Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Annals of the Rheumatic Diseases|March 29, 2007
Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?Elisabeth Hjardem, Mikkel Østergaard, Jan Pødenphant, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2024
Southern Ocean drives multidecadal atmospheric CO<sub>2</sub> rise during Heinrich StadialsKathleen A Wendt, Christoph Nehrbass-Ahles, Kyle Niezgoda, et al.
Arthritis and Rheumatism|December 30, 2009
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registryMerete Lund Hetland, Ib Jarle Christensen, Ulrik Tarp, et al.
Annals of the Rheumatic Diseases|September 4, 2012
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registryBente Glintborg, Mikkel Østergaard, Niels Steen Krogh, et al.
Rheumatology (Oxford, England)|June 19, 2014
Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIOBente Glintborg, Bjorn Gudbjornsson, Niels Steen Krogh, et al.
Molecular Biology and Evolution|September 2, 2003
Genome engineering reveals large dispensable regions in Bacillus subtilisHelga Westers, Ronald Dorenbos, Jan Maarten van Dijl, et al.
The Journal of Rheumatology|October 3, 2014
Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registryLykke Midtbøll Ørnbjerg, Mikkel Østergaard, Pernille Bøyesen, et al.
BMJ Open|October 26, 2018
Protocol for evaluating and implementing a pragmatic value-based healthcare management model for patients with inflammatory arthritis: a Danish population-based regional cohort and qualitative implementation studyTanja Schjødt Jørgensen, Jens Jørgen Lykkegaard, Annette Hansen, et al.
Rheumatology (Oxford, England)|October 12, 2021
Tapering of TNF inhibitors in axial spondyloarthritis in routine care - 2-year clinical and MRI outcomes and predictors of successful taperingMarie Wetterslev, Stylianos Georgiadis, Inge Juul Sørensen, et al.
The Journal of Rheumatology|October 15, 2023
Occurrence and Prediction of Flare After Tapering of Tumor Necrosis Factor Inhibitors in Patients With Axial SpondyloarthritisMarie Wetterslev, Stylianos Georgiadis, Sara Nysom Christiansen, et al.
Pageof 9